Blepharospasm Patient Survey for Patients With Blepharospasm

Status Completed

Clinical Trial Summary

The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatment, and if there is any improvement in their symptoms with the treatment.

Clinical Trial Description

This study is open to males and females > 18 years and < 81 years with a clinical diagnosis of blepharospasm. ;

Study Design

Related Conditions & MeSH terms

Blepharospasm

Clinical Trial Details

NCT number	NCT01686061
Study type	Observational
Source	Merz Pharmaceuticals GmbH
Contact
Status	Completed
Phase
Start date	September 2012
Completion date	April 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00535938` - MDs on Botox Utility (MOBILITY)	N/A
Recruiting	`NCT05027997` - Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm	Phase 2
Terminated	`NCT03263000` - Photic Blink Reflex in People With Blepharospasm and Increased Blinking
Completed	`NCT03938363` - Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia	N/A
Completed	`NCT02947815` - Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm	Phase 2/Phase 3
Completed	`NCT00406367` - IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm	Phase 3
Completed	`NCT00682760` - Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm	Phase 3
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT05103202` - Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Completed	`NCT04423341` - Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm	Phase 2/Phase 3
Completed	`NCT03269123` - A Mechanical Device for Blepharospasm	N/A
Completed	`NCT00411255` - Brain Stimulation to Treat Blepharospasm or Meige Syndrome	Phase 2
Completed	`NCT00500799` - Brain Changes in Blepharospasm	N/A
Completed	`NCT00761592` - Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm	Phase 4
Completed	`NCT00001784` - Mexiletine for the Treatment of Focal Dystonia	Phase 2
Recruiting	`NCT04939909` - Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasm	Early Phase 1
Completed	`NCT03508882` - Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm	Phase 4
Completed	`NCT01814774` - A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm	N/A
Completed	`NCT00234507` - Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm	Phase 2
Recruiting	`NCT05618470` - Wumeiwan Jiawei Fang Use in Patients With Blepharospasm	Phase 2/Phase 3